FIG. 2.

(A) Liver cancer–free probability in patients stratified by GB_MD and obesity (BMI ≥ 25 kg/m²) in patients with duration of T2D ≥ 10 years and observed for ≥3 years before the occurrence of liver cancer or censor date. (B) Risk association of liver cancer in patients with duration of T2D ≥ 10 years and observed for ≥3 years, stratified by GB_MD and obesity (BMI ≥ 25 kg/m²). Model 1: adjusted for age, sex, and disease duration. Model 2: model 1 plus use of tobacco and alcohol, HDLC, TG, LDLC, ALT, bilirubin, eGFR, microalbuminuria, and macroalbuminuria. Model 3: models 1 and 2 plus use of OGLDs, insulin, LLDs, RAS inhibitors, and history of CVD and heart failure. HRs are expressed in these four groups stratified by GB_MD and BMI (≥25 kg/m²) using low GB_MD plus nonobesity as reference. P for interaction between GB_MD and obesity in Cox regression model is shown in (B). P values were estimated by log‐rank test in (A). Abbreviation: OR, odds ratio.